Clinics in Laboratory Medicine
Volume 25, Issue 1 , Pages 39-59, March 2005

Cationic Trypsinogen Mutations and Pancreatitis

  • Nathan Howes, MB, ChB, MD, FRCS

      Affiliations

    • Department of Surgery and Oncology, University of Liverpool, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom
    • ,
  • William Greenhalf, BSc, PhD

      Affiliations

    • Department of Surgery and Oncology, University of Liverpool, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom
    • ,
  • Deborah D. Stocken, MSc

      Affiliations

    • Department of Cancer Research, UK Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, United Kingdom
    • ,
  • John P. Neoptolemos, MA, MB, ChB, MD, FRCS

      Affiliations

    • Department of Surgery and Oncology, University of Liverpool, 5th Floor, University Clinical Department Building, Daulby Street, Liverpool, L69 3GA, United Kingdom
    • Corresponding Author InformationCorresponding author.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This article was previously published in Howes N, Greenhalf W, Stocken DD, Neoptolemos JP. Cationic trypsinogen mutations and pancreatitis. Gastroenterol Clin North Am 2004;33(4):767–87; with permission.The work undertaken by EUROPAC is funded by grants from the Medical Research Council, North West Cancer Research Fund and Augustus Newnham Foundation, UK; DFG and BMBF of Germany (IZKF Münster grants H3 and D21); Solvay Health Care GmbH, Hanover, Germany; National Institutes of Health grant NIDDK-DK54709 and a Veterans Administration Merit Review grant, USA.Ambry Genetics (Irvine, California-http://www.ambrygen.com/) has an exclusive license for clinical testings.

PII: S0272-2712(04)00113-1

doi:10.1016/j.cll.2004.12.004

Clinics in Laboratory Medicine
Volume 25, Issue 1 , Pages 39-59, March 2005

Article Tools